Dosage and the pharmacokinetics of cytotoxic drugs.
作者信息
Trounce J R
出版信息
Br J Clin Pharmacol. 1979 Sep;8(3):205-7. doi: 10.1111/j.1365-2125.1979.tb01003.x.
Abstract
摘要
相似文献
1
Dosage and the pharmacokinetics of cytotoxic drugs.细胞毒性药物的剂量与药代动力学。
Br J Clin Pharmacol. 1979 Sep;8(3):205-7. doi: 10.1111/j.1365-2125.1979.tb01003.x.
2
[Symposium on pharmacokinetics and technics of antineoplastic agent studies].[抗肿瘤药物的药代动力学与技术研讨会]
Minerva Med. 1971 Apr 7;62(28):1488-90.
3
Pharmacokinetics in experimental and clinical chemotherapy.实验性与临床化疗中的药代动力学
Cancer Chemother Pharmacol. 1986;16(2):198-9. doi: 10.1007/BF00256177.
4
Pharmacokinetically guided dose escalation in phase I clinical trials. Commentary and proposed guidelines. EORTC Pharmacokinetics and Metabolism Group.I期临床试验中基于药代动力学的剂量递增。评论与拟议指南。欧洲癌症研究与治疗组织药代动力学与代谢小组。
Eur J Cancer Clin Oncol. 1987 Jul;23(7):1083-7. doi: 10.1016/0277-5379(87)90365-8.
5
The practical benefits of pharmacokinetics in the use of antineoplastic agents.药代动力学在抗肿瘤药物使用中的实际益处。
Cancer Chemother Pharmacol. 1980;4(3):139-45. doi: 10.1007/BF00254011.
6
Dichloromethotrexate--a critical reassessment.
J Clin Oncol. 1985 Aug;3(8):1148-53. doi: 10.1200/JCO.1985.3.8.1148.
7
[Pharmacokinetics use in anti-cancer therapy (author's transl)].
Sem Hop. 1978;54(41-42):1261-4.
8
[Common principles of antineoplastic chemotherapy and their theoretical basis].[抗肿瘤化疗的共同原则及其理论基础]
Vnitr Lek. 1979 Feb;25(2):178-83.
9
General principles of cancer chemotherapy.
Conn Med. 1976 Mar;40(3):159-68.
10
[Kinetics of the introduction and elimination of 2,6-di-tert butyl-4-methylphenol in humans].
Izv Akad Nauk SSSR Biol. 1969 Nov-Dec;6:843-51.
引用本文的文献
1
Bioorthogonal prodrug activation driven by a strain-promoted 1,3-dipolar cycloaddition.由应变促进的1,3-偶极环加成驱动的生物正交前药活化
Chem Sci. 2015 Feb 1;6(2):1212-1218. doi: 10.1039/c4sc02574a. Epub 2014 Nov 14.
2
Recent progress and clinical importance on pharmacogenetics in cancer therapy.癌症治疗中药物遗传学的最新进展及其临床意义。
Clin Chem Lab Med. 2011 Oct;49(10):1621-32. doi: 10.1515/CCLM.2011.715. Epub 2011 Sep 28.
3
Effects of polysorbate 80 on the absorption and distribution of oral methotrexate (MTX) in mice.聚山梨醇酯80对小鼠口服甲氨蝶呤（MTX）吸收和分布的影响。
Cancer Chemother Pharmacol. 1982;9(3):161-4. doi: 10.1007/BF00257745.
4
Effects of combined alpha and beta adrenoceptor blockade in patients with angina pectoris. A double blind study comparing labetalol with placebo.α和β肾上腺素能受体联合阻滞对心绞痛患者的影响。一项比较拉贝洛尔与安慰剂的双盲研究。
Br Heart J. 1985 Jan;53(1):47-52. doi: 10.1136/hrt.53.1.47.
本文引用的文献
1
Progress and perspectives in the chemotherapy of acute leukemia.
Adv Chemother. 1965;2:269-98. doi: 10.1016/b978-1-4831-9930-6.50011-3.
2
Pharmacodynamics of chemotherapeutic effects: dose-time-response relationships for phase-nonspecific agents.化疗效果的药效学：非特异性时相药物的剂量-时间-反应关系
J Pharm Sci. 1971 Jun;60(6):892-5. doi: 10.1002/jps.2600600618.
3
Methotrexate pharmacokinetics.甲氨蝶呤的药代动力学。
J Pharm Sci. 1971 Aug;60(8):1128-33. doi: 10.1002/jps.2600600803.
4
Comparison of cell proliferation kinetics in human and experimental tumors: response to irradiation.人类肿瘤与实验性肿瘤细胞增殖动力学的比较：对辐射的反应
Cancer Treat Rep. 1976 Dec;60(12):1887-95.
5
Systemic methotrexate toxicity. A pharmacological study of its occurrence after intrathecal administration in a patient with renal failure.全身甲氨蝶呤毒性。肾衰竭患者鞘内给药后其发生情况的药理学研究。
Arch Intern Med. 1976 Nov;136(11):1321-2. doi: 10.1001/archinte.136.11.1321.
6
Physicochemical considerations and pharmacokinetic behavior in delivery of drugs to the central nervous system.
Cancer Treat Rep. 1977 Jul;61(4):527-31.
7
Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.腹膜给药治疗卵巢癌的药代动力学原理。
Cancer Treat Rep. 1978 Jan;62(1):1-11.
8
Pharmacokinetics of 5-fluorouracil: inter-relationship with biochemical kinetics in monitoring therapy.
Clin Pharmacokinet. 1977 Nov-Dec;2(6):437-50. doi: 10.2165/00003088-197702060-00004.
9
Drug interactions with antineoplastic agents.
Cancer Treat Rep. 1977 Oct;61(7):1231-41.
10
Clinical pharmacology of intrathecal methotrexate. II. An improved dosage regimen derived from age-related pharmacokinetics.鞘内注射甲氨蝶呤的临床药理学。II. 基于年龄相关药代动力学得出的改进给药方案。
Cancer Treat Rep. 1977 Nov;61(8):1419-25.
Zotero 插件